Author

Bengisu Akbil

Humboldt-Universität zu BerlinORCID 0000-0002-1263-4313Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Christine GoffinetiD· 1 shared Dominic WoodingiD· 1 shared Dylan PostmusiD· 1 shared Jenny Jansen· 1 shared Oya CingöziD· 1 shared Sui Ting Hui· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Christine GoffinetORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintAug 6, 2025

Synergistic latency reversal by the IAP antagonist AZD5582 and BET inhibitor JQ1, combined with Nef ablation, facilitates immune-mediated elimination of latently HIV-1-infected T-cells

Dylan Postmus, Sui Ting Hui, Bengisu Akbil…·Christine Goffinet

This study shows that combining IAP antagonist AZD5582, BET inhibitor JQ1, and Nef ablation enhances immune-mediated elimination of HIV-1 latently infected T-cells.

DOI 10.1101/2025.08.06.668975

humanbulk RNA-seq